Atlas Trials

Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.

Clinical trial NCT07596992 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07596992
Sponsor
Universidade Federal Fluminense
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Disease (CAD)Oxidative StressInflammation
Start date
2026-05-18
Primary completion
2027-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.